Key terms
About ARAY
Accuray, Inc. is a radiation oncology company, which engages in the development, manufacture, and sale of treatment solutions that include CyberKnife and Tomo Therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Madison, WI.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ARAY news
May 02
9:06am ET
Accuray (ARAY) Gets a Buy from Lake Street
May 02
9:01am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
May 02
6:10am ET
Accuray’s Buy Rating Affirmed Despite Challenges, with Positive Long-Term Growth and Overseas Market Expansion
May 01
4:34pm ET
Accuray lowers FY24 revenue view to $432M-$437M from $460M-$470M
May 01
4:32pm ET
Accuray reports Q3 EPS (6c), consensus (1c)
May 01
4:28pm ET
Accuray Incorporated Adjusts Credit Terms, Plans Investor Presentation
Mar 06
11:25am ET
These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 200%, Say Analysts
Feb 13
5:32am ET
Accuray’s Growth Prospects Bolstered by Strategic Market Expansion and Innovation, Recommends Buy
No recent press releases are available for ARAY
ARAY Financials
Key terms
Ad Feedback
ARAY Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ARAY Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range